Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5882980 | Clinical Lymphoma Myeloma and Leukemia | 2014 | 6 Pages |
Abstract
TKIs appear better than DLI in chronic-phase relapses after myeloablative non-T-cell-depleted HCT. Outcomes were poor in advanced-phase relapses irrespective of treatment modality.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Mohamed Shanavas, Hans A. Messner, Suzanne Kamel-Reid, Eshetu G. Atenafu, Vikas Gupta, John Kuruvilla, Dennis (Dong Hwan) Kim, Jieun Uhm, Anna Lambie, Laura Ellis, Jeffrey H. Lipton,